neurocrine.com - Neurology and Endocrinology Research and Therapy

neurocrine.com Neurology and Endocrinology Research and Therapy
Member Since: 0000-00-00 00:00:00

Neurocrine


neurocrine.com Reviews and Rating

Average Rating: 0 / 5
Total Ratings: 0
0/5

Rate and Review neurocrine.com

Check  neurocrine.com  Stats

Daily Unique PVs Total PVs Unique In Total In Unique Out Total Out
Average 0.0 0.0 0.0 0.0 0.3 0.3
Today 0 0 0 0 0 0
Yesterday 0 0 0 0 0 0
February 14 0 0 0 0 1 1
February 13 0 0 0 0 0 0
February 12 0 0 0 0 0 0
February 11 0 0 0 0 0 0
February 10 0 0 0 0 0 0
February 09 0 0 0 0 0 0
February 08 0 0 0 0 1 1
February 07 0 0 0 0 1 1
Highest 0 0 0 0 3 4
Weekly Unique PVs Total PVs Unique In Total In Unique Out Total Out
Average 0.0 0.0 0.0 0.0 2.3 2.5
This Week 0 0 0 0 1 1
Last Week 0 0 0 0 3 3
Week 05 0 0 0 0 2 3
Week 04 0 0 0 0 6 6
Week 03 0 0 0 0 1 1
Week 02 0 0 0 0 4 4
Week 01 0 0 0 0 2 2
Week 52 0 0 0 0 1 1
Week 51 0 0 0 0 1 1
Week 50 0 0 0 0 2 3
Highest 0 0 0 0 8 8
Monthly Unique PVs Total PVs Unique In Total In Unique Out Total Out
Average 0.0 0.0 0.0 0.0 3.5 3.7
This Month 0 0 0 0 5 6
Last Month 0 0 0 0 13 13
December 18 0 0 0 0 8 9
November 18 0 0 0 0 2 2
October 18 0 0 0 0 3 3
September 18 0 0 0 0 3 3
August 18 0 0 0 0 1 1
July 18 0 0 0 0 0 0
June 18 0 0 0 0 0 0
May 18 0 0 0 0 0 0
Highest 0 0 0 0 19 19
Unique PVs Total PVs Unique In Total In Unique Out Total Out
Overall 0 0 0 0 228 234

neurocrine.com Recent News

  • Neurocrine Biosciences - Official Site
    Thursday 7th of February 2019 06:35:00 PM
    Tardive Dyskinesia is a potentially debilitating movement disorder. We have a novel product approved for the treatment of adults with involuntary movements caused by exposure to dopamine receptor blocking agents....
  • Okta
    Thursday 7th of February 2019 08:48:00 AM
    We would like to show you a description here but the site won’t allow us....
  • Neurocrine | definition of neurocrine by Medical dictionary
    Friday 1st of February 2019 05:49:00 AM
    Biotechnology company Neurocrine Biosciences Inc (NASDAQ:NBIX) said on Wednesday that it will proceed with plans to file the NDA for opicapone for Parkinson's disease during the first half of 2019 based on existing pivotal clinical trial data....
  • NBIX:NASDAQ GS Stock Quote - Neurocrine Biosciences Inc ...
    Wednesday 6th of February 2019 03:59:00 PM
    About Neurocrine Biosciences Inc ... Website www.neurocrine.com. Executives. Name/Title. Dr Kevin C Gorman. CEO/Co-Founder. Matt Abernethy. Chief Financial Officer. Darin M Lippoldt....
  • Jobs with Neurocrine Biosciences, Inc. - BioSpace
    Monday 22nd of October 2018 04:57:00 PM
    Neurocrine Biosciences, Inc. is proud to announce that Kevin Gorman, Ph.D., Chief Executive Officer of Neurocrine Biosciences, received the Entrepreneur Of The Year® 2018 Award in the Life Sciences category in San Diego ....